The novel potential therapeutic target PSMP/MSMP promotes acute kidney injury via CCR2.
Song Z, Yao W, Wang X, Mo Y, Liu Z, Li Q, Jiang L, Wang H, He H, Li N, Zhang Z, Lv P, Zhang Y, Yang L, Wang Y.
Song Z, et al.
Mol Ther. 2024 May 24:S1525-0016(24)00330-7. doi: 10.1016/j.ymthe.2024.05.028. Online ahead of print.
Mol Ther. 2024.
PMID: 38796708